Calcitonin Gene-Related Peptide Receptor Antagonists

DBCAT005079Therapeutic category

Pharmacologic agents that block NOCICEPTIVE PAIN signaling from CALCITONIN GENE-RELATED PEPTIDE RECEPTORS. They may be useful for the treatment of pain associated with MIGRAINE DISORDERS and OSTEOARTHRITIS. A DrugBank category of 8 drugs. 7 of them are approved.

Also known as
Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists

What you can answer from here — as of September 21, 2021

8DrugsEach linked to its full drug card
Listed above
4Drug targetsEvery drug–target pair in the class, with bond type
Sign in
109Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
4Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Calcitonin Gene-Related Peptide Receptor Antagonists share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.

Create Account